Outcomes Rocket · 2026-06-30 · 17 min
Many patients with tremor are caught between medications that lose effectiveness and invasive procedures they may not be ready to pursue. In this episode, Deanna Harshbarger, CEO of Cala Health, discusses how non-invasive bioelectronic medicine is creating a new treatment pathway for patients with essential tremor. She explains how Cala’s wearable therapy measures each patient’s tremor, personalizes stimulation, and uses the peripheral nervous system to interrupt tremor-related signals. Deanna also shares how the company overcame regulatory, reimbursement, and access challenges while building an entirely new category of care. Tune in to learn how patient-centered design, perseverance, and personalized neurostimulation are expanding treatment options for people living with tremor. Resources:
Why Customer Success Is the Next Major Category in MedTech with Rupal Ayer, Senior Director of Customer Success at Solventum63 / 100
Changing the Clinical Value Equation in Orthopedic Care with Nic Aldrich, Vice President of Marketing at OrthAlign
Using AI to Strengthen Clinical Confidence in Procedures with Will Mauldin, Co-Founder and CEO of Rivanna Medical
From Blind Biopsies to Precision: Reinventing Medical Imaging with Reza Khorasaninejad, Founder & CEO at LEADOPTIK
Building Bridges Across the Healthcare Ecosystem with Adam McMullin, CEO of AvaSure